We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current NRIX market cap is 1.74B. The company's latest EPS is USD -2.0321 and P/E is -12.22.
| Quarter End | Aug 2023 | Nov 2023 | Feb 2024 | May 2024 | Aug 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 18.47M | 15.16M | 16.59M | 12.09M | 12.59M |
| Operating Income | -40.01M | -45.33M | -45.22M | -48.54M | -54.61M |
| Net Income | -36.98M | -41.96M | -41.52M | -44.55M | -48.96M |
| Year End November 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 31.12M | 17.82M | 29.75M | 38.63M | 76.99M |
| Operating Income | -22.24M | -64.98M | -117.89M | -183.87M | -155.06M |
| Net Income | -21.7M | -43.24M | -117.19M | -180.36M | -143.95M |
| Quarter End | Aug 2023 | Nov 2023 | Feb 2024 | May 2024 | Aug 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 308.2M | 355.6M | 312.67M | 511.03M | 513.6M |
| Total Liabilities | 74.38M | 155.11M | 143.93M | 140.34M | 136.74M |
| Total Equity | 233.82M | 200.49M | 168.75M | 370.69M | 376.86M |
| Year End November 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 44.05M | 396.34M | 476.77M | 416.76M | 355.6M |
| Total Liabilities | 53.57M | 106.07M | 134.47M | 113.06M | 155.11M |
| Total Equity | -57.71M | 290.27M | 342.3M | 303.7M | 200.49M |
| Quarter End | Aug 2023 | Nov 2023 | Feb 2024 | May 2024 | Aug 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -108.05M | -81.37M | -41.95M | -81.66M | -123.83M |
| Investing | 82.67M | 68.3M | 35.51M | -95.56M | -116.9M |
| Financing | 3.21M | 3.22M | 1.62M | 239.38M | 285.15M |
| Year End November 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 601k | -80k | -84.37M | -159.81M | -81.37M |
| Investing | 8.5M | -254.4M | -108.25M | 27.2M | 68.3M |
| Financing | 126k | 339.02M | 153.88M | 117.19M | 3.22M |
| Market Cap | 1.74B |
| Price to Earnings Ratio | -12.22 |
| Price to Sales Ratio | 22.85 |
| Price to Cash Ratio | 32.2 |
| Price to Book Ratio | 8.77 |
| Dividend Yield | - |
| Shares Outstanding | 70.84M |
| Average Volume (1 week) | 690.81k |
| Average Volume (1 Month) | 869.63k |
| 52 Week Change | 286.59% |
| 52 Week High | 27.60 |
| 52 Week Low | 4.96 |
| Spread (Intraday) | 0.09 (0.37%) |
| Company Name | Nurix Therapeutics Inc |
| Address |
3500 s dupont hwy dover, delaware 19901 |
| Website | https://www.nurixtx.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
